Chief Medical Officer
Doctor of medicine at Université de Genève of Switzerland; postdoctor at Medical College of University of Pennsylvania and Rutgers University. Engaging in the research of new drugs in famous US pharmaceutical enterprises such as Memory and Ikaria, being responsible for or participating in clinical trial projects, including medicine for neurology, psychiatry, critical and severe illness; having considerable experience in clinical project management, trial protocol design, clinical trial report and drug safety monitoring; having published 15 academic papers, and won awards in the academic research and during his work in pharmaceutical enterprises. After returning to China in 2012, he was occupied in the development of new antineoplastic drugs and devoted himself in clinical trials for generic drugs consistency assessment. He has experience in management of domestic Phase I clinical center and held the position of PI at Phase I clinical center in Suzhou for several years.